| Filings | Filing Date | Form Type | Company | Description | AI | Link |
|---|---|---|---|---|---|---|
| Filings | Description | AI | Link | |||
|---|---|---|---|---|---|---|
 CXDOCrexendo, Inc. 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20269:31 AM ET | 8-K | CXDO Crexendo, Inc. | 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 Crexendo, Inc. filed an 8-K on November 9, 2026 furnishing an investor presentation posted to its website under Item 7.01 Regulation FD Disclosure.
The presentation is attached as… | ||
 HIHOHIGHWAY HOLDINGS LTD | Nov 9, 20269:30 AM ET | 13D | HIHO HIGHWAY HOLDINGS LTD | |||
 RBNERobin Energy Ltd. | Nov 9, 20269:30 AM ET | 6-K | RBNE Robin Energy Ltd. | |||
 XLABExascale Labs Holdings Inc. 1.01Material agreement9.01ExhibitsExhibits:EX-10.1EX-10.2+4 | Nov 9, 20269:23 AM ET | 8-K | XLAB Exascale Labs Holdings Inc. | 1.01Material agreement9.01ExhibitsExhibits:EX-10.1EX-10.2+4 | ||
 HOWLWerewolf Therapeutics, Inc. 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20269:22 AM ET | 8-K | HOWL Werewolf Therapeutics, Inc. | 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 Werewolf Therapeutics presented new clinical data at SITC 2026 for its conditionally activated IL-2 (WTX-124) and IL-12 (WTX-330) INDUKINE molecules, both showing antitumor activit… | ||
 NKTXNkarta, Inc. 7.01Reg FD8.01Other events9.01ExhibitsExhibits:EX-99.1EX-99.2 | Nov 9, 20269:20 AM ET | 8-K | NKTX Nkarta, Inc. | 7.01Reg FD8.01Other events9.01ExhibitsExhibits:EX-99.1EX-99.2 Nkarta announced positive initial clinical data for NKX019, its off-the-shelf CD19-directed CAR NK cell therapy, from the Ntrust-2 study in myositis and systemic sclerosis, present… | ||
 ECECOPETROL S.A. Exhibits:EX-99.1 | Nov 9, 20269:19 AM ET | 6-K | EC ECOPETROL S.A. | Exhibits:EX-99.1 | ||
 TMCTMC the metals Co Inc. 7.01Reg FD9.01Exhibits | Nov 9, 20269:16 AM ET | 8-K | TMC TMC the metals Co Inc. | 7.01Reg FD9.01Exhibits TMC the metals company disclosed that its subsidiary TMC USA received a letter from NOAA on November 3, 2026 stating NOAA expects to notify TMC USA by mid-December 2026 of its fina… | ||
 SGRYSurgery Partners, Inc. 1.01Material agreement7.01Reg FD9.01ExhibitsExhibits:EX-2.2EX-99.1 | Nov 9, 20269:15 AM ET | 8-K | SGRY Surgery Partners, Inc. | 1.01Material agreement7.01Reg FD9.01ExhibitsExhibits:EX-2.2EX-99.1 | ||
 RGNTREGENTIS BIOMATERIALS LTD. Exhibits:EX-99.1 | Nov 9, 20269:15 AM ET | 6-K | RGNT REGENTIS BIOMATERIALS LTD. | Exhibits:EX-99.1 | ||
 FOXAFox Corp 8.01Other events9.01ExhibitsExhibits:EX-23.1EX-99.1+1 | Nov 9, 20269:08 AM ET | 8-K/A | FOXA Fox Corp | 8.01Other events9.01ExhibitsExhibits:EX-23.1EX-99.1+1 Fox Corporation filed this 8-K/A to complete disclosures for its acquisition of Roku, Inc., which closed on November 6, 2026 for a combination of cash and FOX Class A common stock.… | ||
 TCGXTCGX Acquisition Corp. | Nov 9, 20269:08 AM ET | 425 | TCGX TCGX Acquisition Corp. | TriGemX Bio, the migraine-focused biotech pursuing a SPAC merger with TCGX Acquisition Corp. (Nasdaq: TCGX), appointed veteran biotech executive Daniel Lynch as Chairman of its boa… | ||
 SGISOMNIGROUP INTERNATIONAL INC. 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20269:07 AM ET | 8-K | SGI SOMNIGROUP INTERNATIONAL INC. | 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 Somnigroup International (NYSE: SGI) furnished an updated investor presentation via an Item 7.01 8-K on November 9, 2026, to be used in investor meetings. The filing contains no ne… | ||
 IPFXInflection Point Acquisition Corp. VI Exhibits:EX-99.1 | Nov 9, 20269:07 AM ET | 425 | IPFX Inflection Point Acquisition Corp. VI | Exhibits:EX-99.1 Inflection Point Acquisition Corp. VI (Nasdaq: IPFX) filed a Form 425 disclosing that merger target Quantum Space will host a Virtual Analyst Day on November 9, 2026, featuring CEO… | ||
 NCELNewcelX Ltd. Exhibits:EX-99.1 | Nov 9, 20269:06 AM ET | 6-K | NCEL NewcelX Ltd. | Exhibits:EX-99.1 | ||
 MGLDMarygold Companies, Inc. 2.02Results of operations9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20269:05 AM ET | 8-K | MGLD Marygold Companies, Inc. | 2.02Results of operations9.01ExhibitsExhibits:EX-99.1 | ||
IPFXInflection Point Acquisition Corp. VI 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20269:04 AM ET | 8-K | IPFX Inflection Point Acquisition Corp. VI | 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 Inflection Point Acquisition Corp. VI (Nasdaq: IPFX) filed an 8-K disclosing that merger target Quantum Space will host a Virtual Analyst Day on November 9, 2026, featuring CEO Jim… | ||
 LULufax Holding Ltd | Nov 9, 20269:04 AM ET | 6-K | LU Lufax Holding Ltd | |||
 MANEVeradermics, Inc 7.01Reg FD8.01Other events9.01ExhibitsExhibits:EX-99.1EX-99.2 | Nov 9, 20269:04 AM ET | 8-K | MANE Veradermics, Inc | 7.01Reg FD8.01Other events9.01ExhibitsExhibits:EX-99.1EX-99.2 Veradermics (NYSE: MANE) announced positive 12-month topline data from Part B of its Phase 2/3 Study '302' of VDPHL01, an extended-release oral minoxidil, in 519 men with pattern h… | ||
 KALAKALA BIO, Inc. 2.02Results of operations9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20269:01 AM ET | 8-K | KALA KALA BIO, Inc. | 2.02Results of operations9.01ExhibitsExhibits:EX-99.1 |
Searching Signal8’s SEC filing archive — filings from Oct 2021 onward.
1-20 of 10,000+ filings